On August 2, 2011
Pfizer’s Gamble: As Sales Decline, CEO Doubles Down on 4 New Drugs
Pfizer’s Q2 2011 earnings show CEO Ian Read is selling the company’s most profitable business and banking on four as-yet unlaunched drugs.
No tags for this post.
0 Comments